Study of influenza virus hemagglutinin by Shen, Jun
RICE UNIVERSITY 
Study of Influenza Virus Hemagglutinin 
By 
Jun Shen 
A THESIS SUBMITTED 
IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE 
Doctor of Philosophy 
APPROVED, THESIS COMMITTEE: 
5rofessor,Cfr£ir 
of Bioengineering, RICE 
iemistry & Mgleettter Biology, BCM 
Yizm Jane Tao, Assistant Professor 
Department of Biochemistry & Cell Biology 
RICE University 
Bruce R. Johnson;Distinguished Faculty Fellow 
Department of Chemistry, RICE University 
Executive Director, Rice Quantum Institute 
HOUSTON, TEXAS 
November 2009 
UMI Number: 3421191 
All rights reserved 
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted. 
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed, 
a note will indicate the deletion. 
UMT 
Dissertation Publishing 
UMI 3421191 
Copyright 2010 by ProQuest LLC. 
All rights reserved. This edition of the work is protected against 
unauthorized copying under Title 17, United States Code. 
A ® 
uest 
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
Reproduced in part with permission from J. Shen, J. Ma, and Q. Wang. Evolutionary 
Trends ofA(HlNl) Influenza Virus Hemagglutinin Since 1918, PLoS ONE. Accepted by 
Oct. 15, 2009. Copyright 2010 Public Library of Science. 
Reproduced in part with permission from J. Shen, B. Kirk, J. Ma, and Q. Wang, 
Diversifying Selective Pressure on Influenza B Virus Hemagglutinin. Journal of Medical 
Virology. (2009)81, 114-124. Copyright 2009 Wiley-Liss, Inc. 
ABSTRACT 
Study of Influenza Virus Hemagglutinin 
by 
Jun Shen 
The suddenly global outbreak of 2009 H1N1 Flu reminds human being the danger 
and severity of influenza virus. The gene of the new strain come from five different 
influenza viruses: North American swine influenza, North American avian influenza, 
human influenza, and two swine influenza viruses typically found in Eurasia. The 
recombination of gene in virus evolvement makes it more and more important to 
understand the evolutionary characteristics of influenza. 
Hemagglutinin (HA), embedded on the surface of influenza virus, is one of two 
virally-coded integral envelope proteins of the virus. The three primary functions of 
hemagglutinin (HA) include receptor binding, membrane fusion, and antigenic variation. 
Study of HA structure and its evolutionary mechanism is crucial to fully understand 
influenza virus. 
In the first chapter, a study of diversifying selective pressure on influenze B virus 
hemagglutinin was reported. All the positively selected sites were located in the four 
epitopes (120-loop, 150-loop, 160-loop and 190-helix) of HA, and all of them have been 
identified in previous studies. This supports a predominant role of antibody selection in 
HA evolution. 
In the second chapter, we studied positive selection analysis of 2009 H1N1 Flu. 
Among a subgroup of human A(H1N1) HAs between 1918-2008, we found strong 
diversifying (positive) selection at HAi 156 and 190. We also analyzed the evolutionary 
trends at HAi 190 and 225 that are critical determinants for receptor-binding specificity of 
A(H1N1) HA. Additional analysis of directional selection was also employed for H1N1 
gene data. 
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CHAPTER One 
Diversifying Selective Pressure on Influenza B Virus Hemagglutinin 
1.1 Abstract 
Influenza B virus hemagglutinin (HA) is a major surface glycoprotein with frequent 
amino-acid substitutions. However, the roles of antibody selection in the amino-acid 
substitutions of HA were still poorly understood. In order to gain insights into this 
important issue, an analysis was conducted on a total of 271 HAi sequences of influenza 
B virus strains isolated during 1940-2007. In this analysis, PAML (Phylogenetic 
Analysis by Maximum Likelihood) package was used to detect the existence of positive 
selection and to identify positively selected sites on HAj. Strikingly, all the positively 
selected sites were located in the four major epitopes (120-loop, 150-loop, 160-loop and 
190-helix) of HA identified in previous studies, thus supporting a predominant role of 
antibody selection in HA evolution. Of particular significance is the involvement of the 
120-loop in positive selection, which may become increasingly important in future field 
isolates. Despite the absence of different subtypes, influenza B virus HA continued to 
evolve into new sublineages, within which the four major epitopes were targeted 
selectively in positive selection. Thus, any newly emerging strains need to be placed in 
the context of their evolutionary history in order to understand and predict their epidemic 
potential. 
Key Words: Positive selection/Antigenic drift/Molecular evolution/Antibody selection 
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1.2 Introduction 
Ever since the isolation of the first influenza B virus strain B/Lee/40 [Krystal et al., 
1982], influenza B virus has remained a serious health problem, contributing to the 
seasonal "flu" epidemics each year. As a major glycoprotein on the surface of influenza B 
virus, HA undergoes constant amino-acid substitutions. The HA protein of current 
circulating influenza B virus strains belongs to one of the two major phylogenetic 
lineages: B/Victoria/2/87 (B/VI)-like and B/Yamagata /16/88 (B/YM)-like [Kanegae et al., 
1990; Rota et al., 1990; Shaw et al , 2002]. 
Over the last 68 years, a large number of amino-acid substitutions on influenza B 
virus HA were observed in field isolates, in monoclonal-antibody escape mutants and in 
egg-adapted variants [Berton et al., 1984; Berton and Webster, 1985; Bootman and 
Robertson, 1988; Hovanec and Air, 1984; Krystal et al., 1982; Krystal et al., 1983; 
Lubeck et al., 1980; Rota et al., 1992; Rota et al., 1990; Verhoeyen et al., 1983; Webster 
and Berton, 1981]. However, it was unclear which of these substitutions the results of 
positive selection were, and what were the roles of antibody selection in the molecular 
evolution of influenza B virus HA. In this context, positive selection is defined as a 
significant excess of amino-acid altering substitutions over silent substitutions in 
nucleotide sequences, since, if completely random, only 24% of nucleotide substitutions 
would cause changes in the encoded amino acids [Air et al., 1990]. 
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Fig 1.1: Major epitopes of influenza B virus HA. The trimeric HA is shown with one 
monomer highlighted in color: Pink for HA1 and yellow for HA2. Mutations in four 
regions, the 120-loop (cyan), 150-loop (green), 160-loop (blue), and 190-helix (red), have 
been found to cause antigenicity variation. 
There was previously a sequence analysis on 49 HAi sequences of recent influenza B 
virus isolates, which identified HAi 75, 197, and 199 (B/HongKong/8/73 HA numbering 
of 75, 194, and 196, respectively) to be under positive evolutionary selection [Pechirra et 
al., 2005]. However, since it did not separate the B/YM-lineage and B/VI-lineage 
strains, this study might have failed to identify those amino-acid positions that were 
selected positively only in one but not the other lineage [Yang et al., 2000]. This was 
particularly problematic for the 150-loop and 160-loop (Fig.1.1), which had become 
specific for B/YM-like and B/VI-like strains, respectively [Nakagawa et al., 2001a; 
Nakagawa et al., 2001b; Nakagawa et al., 2003; Nakagawa et al., 2005; Wang et al., 
2008], Most recently, a larger-scale analysis that used 214 HAi sequences of influenza 
B virus strains has been published [Chen and Holmes, 2008]. Although it separated 
B/YM- and B/VI-lineage strains, the evolution of these lineages into distinct sublineages 
was not taken into account, which limited the accuracy of the positively selected sites 
derived therein [Chen and Holmes, 2008]. 
PAML is a package of programs that analyze DNA and protein sequences using 
maximum likelihood [Yang, 2007]. Using the program CODEML in PAML, the 
nonsynonymous (amino-acid altering substitutions)/synonymous (silent substitutions) rate 
ratio (co) for each codon is calculated as an important indicator of selection pressure at the 
protein level: an co > 1 indicates positive selection [Yang, 2007; Yang et al., 2000]. 
Bayes Empirical Bayes analysis then calculates the posterior probability that each site 
belongs to a particular site class. Sites with high posterior probability of belonging to 
the site class of co > 1 are inferred to be under positive selection [Yang, 2007; Yang et al., 
2000], 
In order to gain insights into the amino-acid positions on influenza B virus HA that 
are truly under positive selective pressure, here a total of 271 HAi sequences of influenza 
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B virus strains isolated between 1940-2007 were analyzed. Based on the phylogenetic 
analysis, these HAi sequences were divided into three major groups: early strains 
(1940-1970), B/YM-like lineage (1972-2005) and B/VI-like lineage (1975-2007). The 
B/YM-lineage was further divided into four sublineages, and the B/VI lineage into two 
sublineages (Fig. 1.4). These seven groups were analyzed by using CODEML in PAML 
version 4 [Yang, 2007; Yang et al., 2000]. The identified positively selected sites were 
located predominantly on the four major antigenic epitopes on HAj: the 120-loop (HAi 
116-137), the 150-loop (HA] 141-150), the 160-loop (HA, 162-167), the 190-helix 
(HAi 194-202), and their respective surrounding regions [Wang et al., 2008] (Fig. 1.5), 
suggesting the important roles of antibody selection in molecular evolution of influenza B 
virus HA. 
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1.3 Materials and Methods 
Phylogenetic analysis 
a) Sequences preparation 
This study focused on the first 340 amino acid residues of mature HA] (1-1020 
nucleotides excluding those corresponding to the signal peptide). A total of 271 HAi 
sequences of influenza B virus strains isolated between 1940-2007 were used in the study. 
These sequences were selected to sample all the years in which influenza B viruses were 
active, and special cares were taken to avoid stains with high similarity and isolated in the 
same regions. All the sequences were obtained from the Influenza Sequence Database 
(Los Alamos National Laboratory, Los Alamos, NM, USA www.flu.lanl.gov) [Macken et 
al., 2001]. The name of the strain was composed of two part, strain type plus serial 
number and year, for example: 
New York 2 -
New York: The location where the virus was collected 
2: Serial number, there may exit another strain NewYork3-90. 
90: The vims sixain, was at 1990...' 
Fig 1.2: Meaning of the strain name. 
All the adopted sequences are saved as fasta format, which are compatible with DNA star 
for further analysis. 
b) Alignment of Sequence and tree drawing 
The CLUSTAL W method [Thompson et al., 1994] with the MEGALIGN program of 
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DNASTAR package (www.dnastar.com) was employed for sequencing alignment and 
phylogenetic analysis. Among all the available methods of sequence alignment, clustal W 
method provide the best sensitivity for the alignment of divergent protein sequences. 
Although most of the sequences used in this work share high similarity, the sequence shift 
in alignment is foremost step for calculation of substitution rate ratio. For Clustal W 
method, PAM250 residue weight table was adopted. 
C S T P A G N D E Q H R K M I L V F Y W 
c 12 C 
s 0 2 s 
T -2 1 3 T 
P -3 1 0 6 P 
A -2 1 1 1 2 A 
G -3 1 0 -1 1 5 G 
N -4 1 0 -1 0 0 2 N 
D -5 0 0 -1 0 1 2 4 D 
E -5 0 0 -1 0 0 1 3 4 E 
Q -5 -1 -1 0 0 -1 1 2 2 4 Q 
H -3 -1 -1 0 -1 -2 2 1 1 3 6 H 
R -4 0 -1 0 -2 -3 0 -1 -1 1 2 6 R 
K -5 0 0 -1 -1 -2 1 0 0 1 0 3 5 K 
M -5 -2 -1 -2 -1 -3 -2 -3 -2 -1 -2 0 0 6 M 
1 -2 -1 0 - 2 -1 -3 -2 -2 -2 -2 -2 -2 -2 2 5 1 
L -6 -3 -2 -3 -2 -4 -3 -4 -3 -2 -2 -3 -3 4 2 6 L 
V -2 -1 0 -1 0 -1 -2 -2 -2 -2 -2 -2 -2 2 4 2 4 V 
F -4 -3 -3 -5 -4 -5 -4 -6 -5 -5 -2 -4 -5 0 1 2 -1 9 F 
Y 0 -3 -3 -5 -3 -5 -2 -4 -4 -4 0 -4 -4 -2 -1 -1 -2 7 10 Y 
W -8 -2 -5 -6 -6 -7 -4 -7 -7 -5 -3 2 -3 -4 -5 -2 -6 0 0 17 W 
C S T P A G N D E Q H R K M 1 L V F Y W 
Table 1.1: Residue Weights of Clustal W method. 
Here is an example of the alignment result of the early strains, one of the seven 
sublineages we studied, is listed as fig 1.3 as the following: 
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Sequence Name | |< Pos = 204 
Consensus 
11 Sequences 
• — — mmmrniMimmmmmm I BBS — M » t S l t f l l * i l w • IBlcB • B U g B H S B 
&ACCA(5iG&AAAACTATeCCCAftACTtTCTCAACT&CACAi;ATCT&&ACi;T55CCTT&i;SCiSACCAAA5T&TAT&i;&&ACCATACCTTC&5Ci 
210 220 230 240 250 260 270 280 290 
Lee-40 
CALee-40 
Bonri-43 
GreatLaJie3-54 
Maryland-59 
Thailajid-62 
Bingl(o)i-E4 
S ingapoi4-54 
05^14-70 
Ru5 5 ia-69 
Uictoria-70 
SACCA&A&SAAAACTATfCCCAAACT&TTTTAACTGCACASATCTCfAC&TGtCCTTC&CTA&ACCAAAATGCATSGSG-AACATACCTTCC&CS 
UACCA&AUSAAAACTAT&CCCAAACT&TTTTSACTGCACA&ATCTStAC&TGJCCTTSSSTA&ACCAAAATSCATSOS&AACATACCTTCC&CS 
SACCAUAtfAAAACTAT&CCCAAACTSTTTCAACTSTACA&ATCTSGAC&TCSCCTTGS&CA&ACCAAAATGCATSCU&AACATACCTTCTtCJ 
GACCAGAGGAAAACTATGCCCAAACTGTCTC&ACTGCACAGATCTGGACGTGGCCTTGGGCAGACCAAAGTGTATGGGGACCATACCTTCGGCA 
GACCAGAGGAAAACTATGCCCAAACTGTCTCAACTGCACAGATATGGACGTGGCCTTGGGCAGACCAAAGT&TATGGGAACCATCCCTTCAGCA 
G AC C AG AGGAAAACT AT GC C C AA ACT GT CT C AACT GC AC AGAT CT GGAC GT GGC CTT AGGC AGAC C AAAGT GT GT GGGGAC C AT AC CTT C GGC A 
GACCAGAGGAAAACTATGCCCAAACTGTCTCAACT&CACAGATCTGGACGTGGCCTTGGGCAGACC AAAGT GT AT GGGGAC C AT AC CTT C GGC A 
G AC C AGAGGAAAACT AT GC C C AAACT GT CT C AACT GC AC AGAT CT GGAC GT GGC CTT GGGC AGAC C AAAGT GT AT GGGG AC C AT AC CTT C GGC A 
G AC C AGAGGGAAACT AT GC C C AAACT &T CT C AACT GC AC AGAT CT GGAC GT GGC CTT GGGC AGGC C AAAAT GT AT GGGGAC C AT AC CTT C GGC A 
GACCAGAGGGAAACTATGCCCAAACTGTCTCAACTGCACAGATCTGGACGTGGCCTTGGGCAGACCAAAGTGTTCGGGGACCATACCTTCGGCi 
GACC AGAGGGAAACT AT GC C C AAACT GT CT C AACT GC AC AGAT CT GG AC GT GGC CTT GGGC AGAC C AAATT GT AT GGGGAC C AT AC CTT C GGC A 
Fig. 1.3: Alignment of early strain. 
In these position marked by red, all the strains possess same sequence, no variance. 
Our calculation focused on these non red areas, which are positions under evolution 
pressure, either synonymous (silent) or nonsynonymous(amino acid altering) substitution. 
All the evolution tree pictures in this paper were also made by DNASTAR, and the 
tree format is rooted tree. 
c) Analysis of selective pressure and setting of PAML 
PAML is open source software for phylogenetic analysis of DNA or protein sequence. 
It analyses all the sequence through comparison of nested statistical models. 
For this analysis, the CODEML program in PAML was used to calculate the 
codon-substitution models for heterogeneous selection pressure at amino-acid positions 
[Yang, 1997; Yang, 2007; Yang et al., 2000; Yang et al., 2005], The models used in this 
study were M0, Mia, M2a, M7 and M8. 
Model NSsites #p Parameters 
M0 (one ratio) 0 1 CO 
Mia (neutral) 1 2 Po (p\ = 1 -po), COo< 1, C0i = 1 
M2a (selection) 2 4 P0,Pl (pi = 1 -Po -pi), (Oo< 1,001 = 1,C02> 1 
M3 (discrete) 3 5 P0,Pl (P2 = 1 -Po-Pl) ®0, tOi, ®2 
M7 (beta) 7 2 p, q 
M8 (beta&co) 8 4 p0 (p\ = 1 - p o ) , p , q,<as> 1 
Table 1.2. Parameters in the site models, #p is the number of free parameters in the « 
distribution. 
Mia (nearly neutral) and M7 (beta) were null models that did not support co > 1. In 
contrast, the alternative models M2a (positive selection) and M8 (beta and co), compared 
to Mia and M7 respectively, each had an additional class that allowed co > 1. 
Likelihood ratio tests (LRT) comparing M2a versus Mia and M8 versus M7 provided test 
for the existence of positive selection. In LRT, twice the log likelihood 
difference, 2 Al = 2(1
 x - 10) , was compared with a x2 distribution to test whether the null 
model was to be rejected, where £o and l\ were the log likelihood for the alternative 
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model and the null model, respectively. In addition, empirical Bayes analysis was 
employed to calculate the posterior probability that each site belonged to a particular site 
class. Sites with high posterior probability of belonging to the site class of co > 1 were 
inferred to be under positive selection. It was shown that Bayes Empirical Bayes, which 
assigned a prior to the model parameters [Deely and Lindley, 1981], worked well for both 
small and large datasets [Yang et al., 2005]. Since some of the subgroups used in this 
study were small, the results from Bayes Empirical Bayes analysis were used throughout 
this study. To account for the insertions and deletions in influenza B virus HAi, the 
numbering of influenza B/HongKong/8/73 HA was used as a reference for all sequences 
[Wang et al., 2008], 
The key control file for CODEML program, Codeml.ctl contains all important parameter 
* sequence data file name 
* tree structure file name 
* main result file name 
* 0,1,2,3,9: how much rubbish on the screen 
* 1: detailed output, 0: concise output 
* 0: user tree; 1: semi-automatic; 2: automatic 
* 3: StepwiseAddition; (4,5):PerturbationNNI; -2: pairwise 
* 0:1/61 each, 1.F1X4, 2:F3X4, 3:codon table 
* 0: no clock, unrooted tree, 1: clock, rooted tree 
* O.equal, +:geometric; -.linear, {l-5:G1974,Miyata,c,p,v} 
for the calculation, 
seqfile = FluB.NUC 
treefile = Flub..DND 
outfile = mlc 
noisy = 3 
verbose = 0 
runmode = 0 
CodonFreq = 2 
clock = 0 
aaDist = 0 
NSsites = 08 * ModeO amd Model 8 will be caculated in this run 
icode = 0 
Mgene = 0 
fix kappa = 0 
kappa =. 3 
fixjomega = 0 
omega = 1.3 
f ixalpha = 0 
alpha = 0.5 
ncatG = 10 
getSE = 0 
RateAncestor = 0 
Small_Diff= ,45e-6 
cleandata — 1 
fixjblength = 0 
* O. one w; 1 .NearlyNeutral; 2:PositiveSelection; 3:discrete; 
* 4 :freqs; 5 .gamma; 6:2gamma; 7:beta; 
* 8:beta&w;9:beta&gamma; 10:3normal 
* O.standardgenetic code; 1 .mammalian mt; 2-10:see below 
* O.rates, 1 .separate; 2:pi, 3.kappa, 4.all 
* 1: kappa fixed, 0: kappa to be estimated 
* initial or fixed kappa 
* 1: omega or omega 1 fixed, 0: estimate 
* initial or fixed omega, for codons or codon-based AAs 
* 0: estimate gamma shape parameter; 1: fix it at alpha 
* initial or fixed alpha, 0: infinity (constant) 
* # of categories in the dG or AdG models of rates 
* 0: don't want them, 1: want S.E.s of estimates 
* (0,1,2): rates (alpha>0) or ancestral states (1 or 2) 
* remove sites with ambiguity data (Lyes, 0:no) 
* 0: ignore, -I: random, 1: initial, 2: fixed 
Several pivotal input of CODEML worth to mention and discuss here: 
Model: set equal to 0, that assume all the branches possess the same ratio co. 
Alpha: refers to the parameter a in gamma distribution for variable substitution rates across sites. 
Clock: Without the clock (clock = 0), unrooted trees should be used, such as ((1,2),3,4) or 
(1,2,(3,4)). 
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1.4 Results 
Phylogenetic relationship of influenza B virus HA 
According to phylogenetic analysis, the 271 HAi sequences were divided into three 
groups: early strains isolated between 1940-1970 (I), B/YM-like lineage since 1972 (II) 
and B/VI-like lineage since 1975 (III). The B/YM-lineage (II) was divided further into 
four (II-z ~ II-zv) sublineages (Fig. 1.4), among which (II-/ - ll-iii) sublineages had been 
described in a previous study [Nerome et al., 1998], whilst the (II-zv) sublineage was 
described here for the first time. The B/VI-lineage (III) was divided further into an 
earlier sublineage (III-z) and a more recent sublineage (III-//) (Fig. 1.4). This large-scale 
phylogenetic analysis uncovered that the divergence of influenza B virus HA into B/YM-
and B/VI-lineages can be dated back to early 1970s, which is much earlier than 
previously thought [Kanegae et al., 1990; Matsuzaki et al., 2004; McCullers et al., 2004; 
Rota et al., 1990] and agrees well with a just-published study [Chen et al., 2007]. 
Positive selection on influenza B virus HA 
To detect positively selected sites in HAi sequence of influenza B virus strains 
between 1940-2007, the analysis using CODEML in PAML was performed individually 
on the seven subgroups (I, II-/ - II-zv, and III-z - z'z) (Fig. 1.4). In all but two cases, the 
LRT statistics (2AI ) for M2a versus Mia and M8 versus M7 were much larger than the 
critical value of %\% ~ 6.63 with degree of freedom (d.f.) set to 1 (Table 1.3, 1.4). 
Thus the LRT tests supported the existence of positive selection on influenza B virus HA. 
The sites with greater than 50% posterior probability to be under positive selective 
pressure in models M2a and M8, obtained from Bayes Empirical Bayes analysis [Yang et 
12 
al., 2005], were listed in Table 1.5. In general, M2a identified fewer sites under positive 
selection than M8 did. Nevertheless, the sites identified in M2a were those of the 
highest posterior probability in M8 (Table 1.5). In contrast, those identified only in M8 
but not in M2a were generally of low posterior probability. To be more conservative, 
most of our discussion was focused on the sites that were identified in M8 model with 
greater than 95% posterior probability to be under positive selection. This cutoff limits 
the false-positive rate to 5~6% or lower [Yang et al., 2005]. It is important to emphasize 
that those of high posterior probability to be under positive selection were not necessarily 
those of the highest mutation rates. Different from influenza A virus HA [Bush et al., 
1999; Yang et al., 2000], a much smaller number of sites on influenza B virus HA were 
subject to positive selection for antigenic drift, consistent with earlier studies [Air et al., 
1990; Chen and Holmes, 2008], 
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L£L 
8.5 . 
6 4 
Nucleotide Substitutions (x1 OO) 
Fig. 1.4: Phylogenetic relationship of 271 HAI sequences used in this study. For all 
sequences, the nucleotide sequences between l and 1,020, corresponding to residues HAI 
1-340, were used. The phylogenetic tree was drawn using the program Megalign from 
DNASTAR package (www.dnastar.com). 
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Fig 1.5: Sites with posterior probabilities of greater than50% to be under positive 
selection in the M8 models for the seven subgroups of influenza B virus HA, in the order 
of early strain (I) (a), B/YM-lineage (II-i-II-iv) (b-e) and B/VI-lineage (Ill-i and Ill-ii) (f, 
g). Each site is shown as a ball centered at its Ca atom in the structure (Protein Data Bank 
code 3BT6) [Wang et al., 2008], Sites with greater than 95% posterior probability to be 
under positive selection are shown in dark color and the rest are in light color. The 
structure of one monomer of HA is in the same orientation as the monomer shown in 
color in Figure 1.1. 
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Tablel.3: The values of log-likelihood (£), d^/ds, and parameter estimates in the analysis 
of the HAi subunit of influenza B virus strains circulating between 1940-2007. 
Model I d^lds Parameters estimates 
Early strain (I) 1940-1970 (11 strains) 
M0 (one-ratio) -2343.24 0.271 co=0.271 
Mia (nearly neutral) -2317.53 0.258 p0=0.744 (p,=0.256), co0=0.002 (co,=l) 
M2a (positive selection) -2314.85 0.297 /?o=0.744,/?i=0.251 O2=0.005), co0=0.005 (CO,=1), co2=7.990 
M7 (beta) -2317.89 0.236 p=0.016, 9=0.051 
M8 (beta&co) -2315.01 0.287 p0=0.994 (p,=0.006), p=0.017, <7=0.051, cos=7.428 
B/YM-lineage (11-0 1972-1984 (25 strains) 
M0 (one-ratio) -2501.04 0.373 co=0.373 
Mia (nearly neutral) -2461.96 0.262 p0=0.755 (p!=0.245), (O0=0.022 (co,=l) 
M2a (positive selection) -2439.17 0.404 />o=0.729,/?,=0.261 O2=0.011>, co0=0.020 (co,=l), co2=l 1.904 
M7 (beta) -2462.35 0.300 p=0.005, 9=0.012 
M8 (beta&co) -2439.28 0.426 A>=0.989 (A7,=0.011), p=0.017, 9=0.042, cos=12.282 
B/YM-lineage (II-M) 1987-1996 (24 strains) 
M0 (one-ratio) -2032.98 0.311 co=0.311 
Mia (nearly neutral) -2002.40 0.188 p0=0.812 (p,=0A 88), co0=0 (coi=1) 
M2a (positive selection) -1995.15 0.318 p0=0.826,p,=0.136 (p2=0.038), co0=0 (co,=l), co2=4.779 
M7 (beta) -2002.45 0.200 p=0.005, 9=0.020 
M8 (beta&co) -1995.32 0.313 p0=0.953 (pi=0.047), p=0.012, <7=0.076, cos=4.237 
B/YM-lineage (H-iit) 1991-2002 (56 strains) 
M0 (one-ratio) -2211.56 0.200 co=0.200 
Mia (nearly neutral) -2196.38 0.168 /?o=0.901 (p,=0.099), coo=0.077 (co,=l) 
M2a (positive selection) -2190.27 0.213 ^o=0.936,p!=0.056 (p2=0.009), (o0=0.105 (co^l), co2=6.802 
M7 (beta) -2197.92 0.184 p=0.098, 9=0.437 
M8 (beta&co) -2190.51 0.212 Po=0.991 (pi=0.009), p=0.431, 9=2.312, cos=6.740 
B/YM-lineage (H-iv) 1994-2005 (33 strains) 
M0 (one-ratio) -2144.23 0.220 co=0.220 
Mia (nearly neutral) -2127.98 0.211 p0=0.789 (pi=0.211), co0=0 (co,= l) 
M2a (positive selection) -2127.40 0.242 /?o=0.847, p\=0.022 (p2=0.131), coo=0.021 (co,=l), co2=1.537 
M7 (beta) -2128.03 0.200 p=0.005, 9=0.020 
M8 (beta&co) -2127.40 0.242 Po=0.868 (pi=0.132), p=0.052, 9=1.023, cos=1.560 
B/VI-lineage (m-i) 1975-1993 (24 strains) 
M0 (one-ratio) -2530.27 0.336 co=0.336 
Mia (nearly neutral) -2492.37 0.251 p0=0.749 (fi=0.251), co0=0 (tox=l) 
M2a (positive selection) -2477.70 0.351 /?o=0.736,pi=0.254 (p2=0.010), co0=0.005 (co^l), co2=9.700 
M7 (beta) -2492.81 0.222 p=0.009, 9=0.029 
M8 (beta&co) -2477.89 0.354 A)=0.983 (,£>,=0.017), ,0=0.016, 9=0.050, cos=7.267 
B/VI-lineage ( m - I T ) 1996-2007 (98 strains) 
M0 (one-ratio) -2924.64 0.299 co=0.299 
Mia (nearly neutral) -2899.56 0.266 p0=0.805 (p,=0.195), co0=0.088 (co,=l) 
M2a (positive selection) -2887.74 0.320 p0=0.796,p1=0.199 0?2=0.005), co0=0.094 (co,=l), co2=9.871 
M7 (beta) -2899.97 0.266 /?=0.156, 9=0.430 
M8 (beta&co) -2887.00 0.309 p0=0.994 (^=0.006), p=0.244, 9=0.698, cos=8.534 
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Table 1.4: Likelihood ratio tests (LRT) between M2a versus Mia and M8 versus M7 for 
the seven subgroups of HAi subunit of influenza B virus strains circulating between 
1940-2007 
LRT 2A^ 
Early strain (I) 1940-1970 (11 strains) 
M2a - Mia 5.36 
M 8 - M 7 5!76 
B/YM-lineage (II-i) 1972-1984 (25 strains) 
M2a - Mia 44.44 
M 8 - M 7 46.14 
B/YM-lineage (II-//) 1987-1996 (24 strains) 
M2a - Mia 14.50 
M 8 - M 7 14.26 
B/YM-lineage (II-///) 1991-2002 (56 strains) 
M2a - Mia 12.22 
M 8 - M 7 14.82 
B/YM-lineage (II-/v) 1994-2005 (33 strains) 
M2a - Mia 1.16 
M 8 - M 7 L26 
B/VI-lineage (III-/) 1975-1993 (24 strains) 
M2a - Mia 29.34 
M 8 - M 7 29.84 
B/VI-lineage (III-//) 1996-2007 (98 strains) 
M2a - Mia 23.64 
M8 - M7 25.94 
' In LRT tests, the values of 2A£ were compared with the critical values of %2 distribution 
(9.21 and 5.99 for z k and J52„/o , respectively, with d.f.=2) [Yang, 1997; Yang, 2007; 
Yang et al., 2000; Yang et al., 2005]. Significantly larger values of 2Ai over those of 
% distributions led to the rejection of the null models Mia and M7. 
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Table 1.5 Sites with higher than 50% posterior probabilities of being under positive 
selective pressure for the HAi subunit of influenza B virus strains circulating between 
1940-2007 
Model Positively selected sites 
Early strain (I) 1940-1970 (11 strains) 
M2a (positive selectio 73, 150, 167*, 194", 196, 238 
M8 (beta&co) 73*, 121, 122, 123, 136, 146, 150*, 154*, 160, 167***, 
194***, 196**, 206, 238* 
B/YM-lineage (II-i) 1972-1984 (25 strains) 
M2a (positive selectio 122, 129***, 194***, 196***, 206 
M8 (beta&co) 48, 122**, 129***, 137, 194***, 195, 196***, 206**, 230 
B/YM-lineage (II-i7) 1987-1996 (24 strains) 
M2a (positive selectio 68*, 75**, 122, 129, 150**, 194***, 196***, 200, 227**, 295* 
M8 (beta&co) 68**, 73, 75***, 105, 122*, 129**, 149, 150***, 194***, 196*' 
199, 200, 227***, 295*** 
B/YM-lineage (IWii) 1991-2002 (56 strains) 
M2a (positive selectio 176, 194***, 196*** 
M8 (beta&co) 75, 149, 176*, 194***, 196***, 206 
B/YM-lineage (II-iv) 1994-2005 (33 strains) 
M2a (positive selectio 69*, 177**, 194, 196 
M8 (beta&co) 56, 69**, 118, 126, 177***, 194**, 196** 
B/VI-lineage (III-i) 1975-1993 (24 strains) 
M2a (positive selectio 73*, 116, 167**, 194***, 196***, 290, 328 
M8 (beta&co) 68, 73***, 116**, 129, 137, 146, 167***, 194***, 196***, 
290**, 328** 
B/VI-lineage (Ill-ii) 1996-2007 (98 strains) 
M2a (positive selectio 194***, 196*** 
M8 (beta&co) 80,121*, 129, 194***, 196*** 
Positively selected sites from Bayes Empirical Bayes analysis [Yang et al., 2005]. 
*Posterior probability of positive selective pressure is between 75-84%. 
**Posterior probability of positive selective pressure is between 85-94%. 
***Posterior probability of positive selective pressure is higher than 95%. 
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Early strain (I) (1940-1970). 
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Fig. 1.6: Early strain lineage (I). 
Among the 271 HAi sequences analyzed in this study, a total of 11 sequences over a 
time span of 31 years belong to this group (Fig. 1.4, Fig. 1.6). To limit the uncertainties 
related to the relatively small number of samples in this group, the results from Bayes 
Empirical Bayes analysis were used throughout this study [Anisimova et al., 2002; Yang 
etal., 2005]. In LRT tests, the values of 2AI were 5.36 for M2a versus Mia, and 5.76 
for M8 versus M7 (Table 1.4). These values were larger than the critical value of x]% 
3.84. but smaller than z L = 6.63 with d.f. = 1 [Yang, 1997; Yang, 2007; Yang et al., 
2000; Yang et al., 2005]. The M2a model suggested -0.5% sites to be under positive 
selection with co2=7.990 (Table 1.3). Similarly, the M8 model suggested -0.6% sites to 
be under positive selection with cos=7.428. The M2a model identified a total of six sites 
to be under positive selective pressure (>50% posterior probability) (Table 1.5). The M8 
model identified 14 sites of being under positive selective pressure (>50% posterior 
probability) (Fig. 1.6). Among them, two sites were of greater than 95% posterior 
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probability to be under positive selection: HAj 167 (95%) on the 160-loop and 194 (99%) 
on the 190-helix. 
B/YM-like lineage (II). 
A total of 138 HAi sequences in this analysis belong to B/YM-like lineage. It was 
further divided into four sublineages, II-z (25 sequences), II-// (24 sequences), II-/// (56 
sequences) and II-/v (33 sequences) (Fig. 1.4). 
Early strain sublineage (II-/) (1972-1984). 
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Fig. 1.7: B/YM-lineage 11-/(1972-1984) 
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These early strains of B/YM-lineage spanned a period of 13 years (Fig. 1.7). The 
values of M2a versus Mia and M8 versus M7 were much greater than = 6.63 with d.f. 
= 1 (Table 1.3, 1.4), resulting in the rejection of the null models Mia and M7. Both 
M2a and M8 models suggested -1.1% sites to be under strong positive selection with 
large values (Table 1.3). The M2a model identified a total of five sites to be under 
positive selection (>50% posterior probability) (Table 1.5), three of which were of greater 
than 95% posterior probability: HAI 129 (97%) on the 120-loop, 194 (100%) and 196 
(100%) on the 190-helix. These three sites were again with >95% posterior probability 
in the M8 model: HAI 129 (99%), 194 (100%) and 196 (100%) (Fig. 1.7). 
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Sublineage (Il-ii) (1987-1996). 
Lisboa 1 0 - 9 4 
— L i s b o a 2 7 - 9 5 
— L i s b o a 2 3 - 9 5 
i f — L i s b o a 2 - 9 4 
L ' i sboa5-94 
L i s b o a 2 6 - 9 5 
- Tokushima 101 - 9 3 
Finland254—93 
F, 
M e m p h i s 2 0 - 9 6 
Houston 1 - 9 1 
Nashville45—91 
Aichil - 9 1 
T e x a s 4 - 9 0 
Texasl - 9 1 
Banqkokl 6 3 - 9 0 
- Sou thDako ta5 -89 
NewYork3 -90 
Shanqhai l 2 - 8 7 
• Yamaqoto l 6 - 8 8 
G u a n q d o n q 5 5 - 8 9 
- HonqKonq9 -89 
- H o n q K o n q 2 2 - 8 9 
- P a n a m a 4 5 - 9 0 
" S i n q a p o r e 7 - 8 8 
0 
Nucleotide Substi tut ions fx lOO) 
Fig. 1.8: B/YM-lineage II-// 
The B/YM-lineage strains in this group covered a 10-year period (Fig. 1.8). In 
LRT tests, the 2AI values of M2a versus Mia and M8 versus M7 provided strong 
support for the existence of positive selection (Table 1.3, 1.4). Both M2a and M8 
2 2 
models suggested ~4% sites to be under positive selection with co - 4 (Table 1.3). The 
M2a model identified two sites with higher than 95% posterior probability of being 
positively selected (Table 1.5): HA! 194 (99%) and 196 (97%) on the 190-helix. The 
M8 model identified a total of six sites with greater than 95% posterior probability of 
being positively selected (Table 1.5): HAi 75 (97%) and 295 (98%) on the 120-loop, 150 
(96%) on the 150-loop, 194 (100%), 196 (99%) and 227 (97%) on the 190-helix (Fig. 
1.8). It is noteworthy that HAi 150 on the 150-loop was inferred to be under positive 
selection with very high confidence, in excellent agreement with previous conclusions 
that the 150-loop is an important epitope for B/YM-lineage [Nakagawa et al., 2001a; 
Nakagawa et al., 2003]. 
Sublineage (II-«i) (1991-2002). This sublineage of B/YM-like strains covered 
a 12-year period (Fig. 1.9). The LRT tests led to the rejection of the null models Mia 
and M7 (Table 1.3, 1.4). Both M2a and M8 models suggested -0.9% sites to be under 
positive selection with co ~ 7 (Table 1.3, 1.4). The M2a model revealed three sites of 
being under positive selection, including HAi 194 (97%) and 196 (99%) on the 190-helix 
(Table 1.5). These two sites were of 99% and 100% posterior probability of positive 
selection in the M8 model (Table 1.5 and Fig. 1.9). 
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Fig. 1.9: B/YM-lineage ll-iii. 
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Sublineage (II-/V) (1994-2005). 
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Fig. 1.10: B/YM-lineage II-zv. 
This sublineage of B/YM-like strains contained some of the most recently circulating 
2 5 
strains of B/YM-lineage (Fig. 1.10). In sharp contrast to all other sublineages of 
B/YM-like strains and to all B/VI-like strains, the LRT statistics were 2AI =1.16 and 
1.26 for M2a versus Mia and M8 versus M7, respectively (Table 1.4), suggesting a low 
confidence for the existence of positive selection. In Bayes Empirical Bayes analysis, 
both M2a and M8 models suggested a relatively large percentage of sites (-13%) to be 
under very weak positive selection with ©2=1.537 and cos=1.560, respectively (Table 1.3). 
The M2a model identified a total of four positively selected sites with >50% posterior 
probability (Table 1.5). In the M8 model, a total of seven sites were identified, with 
only one site, HAi 177 (98%) on the 120-loop, with > 95% posterior probability (Table 
1.5 and Fig. 1.10). This sublineage was the only group in which HAt 194 and 196 are 
of lower than 95% probability to be under positive selection. 
B/VI-like lineage (III). A total of 122 HAi sequences of influenza B virus strains 
belong to this lineage. They were grouped into two sublineages, early strains (III-/) 
containing 24 sequences and more recent strains (III-//) containing 98 sequences (Fig. 
1.4). 
Early strain sublineage (Ill-i) (1975~1993). These early strains of 
B/VI-lineage spanned a time period of 19 years and exhibited significant sequence 
differences from the recent circulating B/VI-like strains (III-//) (Fig.2, Fig. 1.11). The 
LRT statistics supported the rejection of the null models (Mia and M7) and strongly 
supporting the presence of positive selection (Table 1.3, 1.4). The M2a model 
suggested 1.0% sites to be under positive selection with 0)2=9.700 (Table 1.3). Similarly, 
the M8 model suggested 1.7% sites to be under positive selection with cos-7.267. The 
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Fig. 1.11: B/VI-lineage III-/. 
M2a model identified seven sites to be under positive selective pressure (Table 1.5), with 
HAi 194 (100%) and 196 (100%) on the 190-helix of higher than 95% posterior 
probability. The M8 model revealed a total of 11 positively selected sites, among which 
four sites were of greater than 95% posterior probability. They were HAi 73 (95%) 
(120-loop), 167 (97%) (160-loop), 194 (100%) and 196 (100%) (190-helix) (Table 1.5, 
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Fig. 1.11). It is important to note that among these four sites with the highest posterior 
probability, one site, HAi 167, is on the 160-loop, while none is located on the 150-loop. 
In sharp contrast, B/YM-like (II-//) sublineage, which circulated in an overlapping time 
period and contained the same number of sequences, had HAi 150 on the 150-loop to be 
under positive selection. These observations further supported earlier conclusions that 
the 160-loop epitope is specific for the B/VI-lineage strains [Nakagawa et al., 2001b; 
Nakagawa et al., 2005] while the 150-loop epitope is specific for the B/YM-lineage 
strains [Nakagawa et al., 2001a; Nakagawa et al., 2003]. 
Recent strain sublineage (III-ii) (1996-2007). 
The more recent isolates of B/VI-lineage strains remained to be a single group over the 
time period of 12 years (Fig. 1.12). The LRT statistics supported strongly the presence 
of positive selection (Table 1.3,1.4). The M2a model suggested -0.5% sites to be under 
positive selection with (02=9.871 (Table 1.3). Similarly, the M8 model suggested -0.6% 
sites to be under positive selection with cos=8.534. HAi 194 had a posterior probability 
of 95% and 99% to be under positive selection in M2a and M8 models, respectively, 
while HAi 196 has a 100% posterior probability in both M2a and M8 models (Table 1.5 
and Fig. 1.12). Compared to the earlier B/VI-like (III-/) sublineage, one noticeable 
difference is that the 160-loop was no longer under positive selection in these recent 
strains (III-//). Rather, positive selection was focused on the 190-helix. 
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1.5 Discussion and Conclusions 
Roles of antibody selection in the evolution of influenza B virus HA 
In previous studies, four major antigenic epitopes of influenza B virus HA, the 
120-loop, the 150-loop, the 160-loop, and the 190-helix, were identified on the 
membrane-distal domain of HAi [Wang et al., 2008] (Fig.1.1), Strikingly, in this study, 
all the identified positively selected sites in the seven subgroups were located on these 
four major antigenic epitopes, supporting the important roles of antibody selection in the 
molecular evolution of influenza B virus HA. 
The 150-loop is an important epitope on HA. Antigenic properties were altered 
for influenza B virus with mutations on this loop in laboratory-selected escape mutants 
[Berton et al., 1984; Berton and Webster, 1985; Nakagawa et al., 2003; Webster and 
Berton, 1981], field isolates [Abed et al., 2003; Nakagawa et al., 2001a] and egg-adapted 
variants [Lugovtsev et al., 2005; Lugovtsev et al., 2007; Oxford et al., 1991; Oxford et al., 
1990]. In more recent influenza B virus isolates, the 150-loop region appeared to be the 
neutralizing epitope specific for B/YM-like strains [Nakagawa et al., 2001a; Nakagawa et 
al., 2003]. Consistent with that finding, HAi 150 was under positive selection with 96% 
posterior probability in B/YM-like (II-//) sublineage. 
The 160-loop is the only region in influenza B virus HA where insertions, 
deletions and single amino-acid substitutions were detected in field isolates [McCullers et 
al., 1999; Nakagawa et al., 2005; Nerome et al., 1998] and mAb-escape mutants [Berton 
et al., 1984; Berton and Webster, 1985; Nakagawa et al., 2001a; Nakagawa et al., 2001b; 
Webster and Berton, 1981], as an effective way for influenza B virus to survive a long 
period of time without antigenic shifts as observed in influenza A virus [Nerome et al., 
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1998]. In recent isolates, the 160-loop became specific for B/VI-like lineage [Nakagawa 
et al., 2001b; Nakagawa et al., 2005]. In agreement with this observation, HAi 167 on 
the 160-loop was selected positively in early strains (I) and in B/VI-like (III-/) sublineage 
(Table 1.5, Fig.1.5), with 95% and 96% posterior probability, respectively. 
The 190-helix, which forms part of the receptor-binding site (RBS) of influenza B 
virus HA, is inarguably one of the most important epitopes. The hot spot is at HAi 
194-196, a potential glycosylation site. Similar to influenza A virus HA [Caton et al., 
1982; Daniels et al., 1983; Schulze, 1997; Skehel et al., 1984; Skehel and Wiley, 2000], 
influenza B virus HA also utilized the addition or removal of glycosylation as a 
mechanism for antigenic drift [Berton et al., 1984; Berton and Webster, 1985; Gambaryan 
et al., 1999; Ikonen et al., 2005; Muyanga et al., 2001; Nakagawa et al., 2000; Nakagawa 
et al., 2004; Oxford et al., 1991; Oxford et al., 1990; Robertson et al., 1990; Robertson et 
al., 1985; Saito et al., 2004; Schild et al., 1983; Wang et al., 2008]. In this current 
analysis, HAi 194 and 196 were constantly identified to be under positive selective 
pressure, with greater than 99% probability in 11 out of 14 cumulative cases (combining 
both sites in seven groups), and over 85% in three other cases. HAi 227 in sublineage 
(II-//) was another positively selected site on 190-helix with high posterior probability 
(97%) (Table 1.5, Fig. 1.5). 
Perhaps one of the most important observations from this study is positive 
selection of the 120-loop region. The 120-loop epitope was defined as HAi 116-137 
and its surrounding regions [Wang et al., 2008]. In this context of this article, we refer 
to all sites not adjoining the 150-loop, 160-loop or the 190-helix epitopes as the 120-loop 
region due to spatial proximity (Fig.1.1). Although the 120-loop region appeared to be 
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one of the most frequently mutated regions in field isolates [Verhoeyen et al., 1983], its 
role in antigenicity of influenza B virus HA was not recognized until most recently 
[Lugovtsev et al., 2007; Nakagawa et al., 2006; Wang et al., 2008], One possibility for 
such a delay in recognition is that the 120-loop is proximal to the viral envelope 
membrane, making the access by antibodies more difficult, as observed for influenza A 
virus HA [Barbey-Martin et al., 2002; Bizebard et al., 2001; Bizebard et al., 1995; Fleury 
et al., 1999; Gigant et al., 2000; Knossow et al., 2002]. Thus, it is very important that 
this current study provided strong evidence for positive selection of the 120-loop region, 
further supporting its significance in antigenicity of influenza B virus HA. 
Trends of positive selection on influenza B virus HA 
The early strains (I) seemed to have rather even distribution of positive selective 
pressure on all four major epitopes, although the positive selection on the 160-loop and 
190-helix appeared to be stronger and/or more prevailing (Table 1.5, Fig. 1.6). In 
contrast, the early strains of B/YM-lineage and B/VI-lineage, sublineages (II-//) and (III-/) 
respectively, were sharply divided. HAi 150 on the 150-loop in B/YM-like (II-//) 
sublineage, and HAi 167 on the 160-loop in B/VI-like (III-/) sublineage, were inferred to 
be under positive selection with high posterior probability (Table 1.5). These 
observations agreed very well with earlier studies in which the 150-loop and 160-loop 
were found to be specific epitopes for the B/YM- and B/VI-lineages, respectively 
[Nakagawa et al., 2001a; Nakagawa et al., 2001b; Nakagawa et al., 2003; Nakagawa et al., 
2005]. However, despite large sequence differences, the recent B/YM-like (II-z'z'z') 
sublineage and B/VI-like (III-//) sublineage converged at focusing on the 190-helix for 
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antigenic drift (Table 1.5 and Fig. 1.5). Most strikingly, in the newest B/YM-like (II-zv) 
sublineage, a large number of sites were found to be under rather weak positive selection, 
and the only positively selected site identified with high confidence was HAi 177 on the 
120-loop. The new trends of positive selection among these most recent strains, in 
conjunction with results from other studies [Lugovtsev et al., 2007; Nakagawa et al., 
2006], stress the increasingly important role of the 120-loop in antigenicity of influenza B 
virus HA. 
Concluding remarks 
This study reports a large-scale systematic analysis of diversifying positive 
selective pressure on HA of distinct lineages/sublineages of influenza B virus isolated in 
the past 68 years. The highlights of the results from this study are: 
a). The number of positively selected sites in influenza B virus HA were much 
fewer than those of influenza A virus HA [Air et al., 1990]; 
b). Although it does not have subtypes as influenza A virus HA, influenza B 
virus HA did and continue to diverge into different sublineages. This was particularly 
true for B/YM-lineage, as exemplified by the newly emerging B/YM-like (II-zv) 
sublineage that had not been previously described. 
c). The study revealed the predominant roles of antibody selection in the 
molecular evolution of influenza B virus HA. 
d). Despite the differences among different lineages/sublineages, HAi 194 and 
196 were constantly under positive selective pressure in all but one cases. 
e). The 120-loop was an important epitope under constant positive selection. It 
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may play an increasingly important role in antigenicity in future field isolates, as 
evidenced in the most recent B/YM-like (II-/v) sublineage (Table 1.5). 
f). Each lineage/sublineage utilized their respective favorite sites in positive 
selection. Thus, for any newly emerging strains of influenza B virus, it is important to 
put them in the context of their evolutionary history in order to understand and appreciate 
their full epidemic potential. 
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Chapter Two 
Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin 
Since 1918 
2.1 Abstract 
The Pandemic (H1N1) 2009 is spreading to numerous countries and causing many 
human deaths. Although the symptoms in humans are mild at present, fears are that 
further mutations in the virus could lead to a potentially more dangerous outbreak in 
subsequent months. As the primary immunity-eliciting antigen, hemagglutinin (HA) is 
the major agent for host-driven antigenic drift in A(H3N2) virus. However, whether and 
how the evolution of HA is influenced by existing immunity is poorly understood for 
A(H1N1). Here, by analyzing hundreds of A(H1N1) HA sequences since 1918, we 
show the first evidence that host selections are indeed present in A(H1N1) HAs. Among 
a subgroup of human A(H1N1) HAs between 1918-2008, we found strong diversifying 
(positive) selection at HAi 156 and 190. We also analyzed the evolutionary trends at 
HAi 190 and 225 that are critical determinants for receptor-binding specificity of 
A(H1N1) HA. Different A(H1N1) viruses appeared to favor one of these two sites in 
host-driven antigenic drift: epidemic A(H1N1) HAs favor HAi 190 while the 1918 
pandemic and swine HAs favor HAi 225. Thus, our results highlight the urgency to 
understand the interplay between antigenic drift and receptor binding in HA evolution, 
and provide molecular signatures for monitoring future antigenically drifted 2009 
pandemic and seasonal A(H1N1) influenza viruses. 
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Figure 2.S1: 
Phylogenetic tree of 333 HA sequences of A(H1N1) 
influenza viruses isolated between 1918-2009 
without egg-adaptation. 
2.2 Introduction and background 
Since April 2009, a global outbreak caused by the swine-origin 2009 A(H1N1) 
influenza virus has spread to numerous countries [1,2,3,4,5,6,7,8,9,10], which warranted 
the declaration of "Pandemic (H1N1) 2009" by the World Health Organization on June 11, 
2009. As of September 6, there had been over 277,607 infected individuals and at least 
3,205 confirmed human deaths worldwide. 
The Pandemic (H1N1) 2009 is not the first human pandemic caused by A(H1N1) 
influenza virus. During 1918-1919, the "Spanish" A(H1N1) influenza virus swept 
across the globe, infected -25% of the entire population and claimed at least 50 million 
human lives worldwide [11]. In subsequent years, A(H1N1) influenza virus continued 
to circulate among humans and caused a number of severe outbreaks between 1920s and 
1950s [12,13,14,15,16,17,18,19,20], in particular the A(H1N1) epidemic in 1950-1951 
with mortality exceeding those of the 1957 "Asian" and 1968 "Hong Kong" pandemics 
[18,19,20]. In 1957, A(H1N1) influenza virus disappeared, replaced by a reassorted 
A(H2N2) influenza virus [21]. However, the A(H1N1) influenza virus reappeared in 
1977, with a close genetic and antigenic similarity to those A(H1N1) viruses isolated in 
1950 [22,23,24], and has co-circulated with A(H3N2) and type B influenza virus to cause 
seasonal human epidemics ever since. 
The same 1918 pandemic A(H1N1) influenza virus was also spread to swine during 
1918-1919, and became the so-called "classical" swine influenza [8,25,26,27], first 
isolated in North American in 1930 [26] and in Europe in 1976 [28,29]. In 1979, a novel 
lineage of avian-like A(H1N1) influenza virus, believed to have derived from closely 
related Eurasia avian influenza viruses, emerged in swine in Europe [30] and replaced the 
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classical swine A(H1N1) virus in this region [31,32,33]. These two classes of swine 
A(H1N1) viruses displayed different evolutionary trajectories [34], Inl998, a new 
triple-reassortant A(H3N2) virus, derived from North American avian, classical swine 
A(H1N1) and human A(H3N2) viruses, caused outbreaks in North American swine 
[35,36]. Mixing of the triple-reassortant H3N2 with established swine lineages gave rise 
to H1N1 and H1N2 reassortant swine viruses [37,38]. Since 2007, human infection 
caused by A(H1N1) swine virus has become a health concern in the United States [7]. 
The 2009 A(H1N1) influenza virus has its origin as a reassortant from a Eurasian 
avian-like swine A(H1N1) virus and a triple-reassortant virus circulating in North 
American swine [1,2,3,4,5,6,7,8]. As such, the 2009 A(H1N1) virus contains NA and M 
from Eurasian avian-like swine A(H1N1) virus, and the remaining genes from the 
triple-reassortant virus - PB2 and PA (avian virus), PB1 (human A(H3N2)), and HA, NP 
and NS (classical swine A(H1N1)) [1,2,3,4,5,6,7,8]. In a sense, we are continuingly 
living in a pandemic that started in 1918 [27]. Thus, it is not surprising for the similarly 
mild first waves of the 1918 and 2009 pandemics. Notably, the second wave of the 
"Spanish" influenza in the fall of 1918 became much more lethal, peaked within one 
month of the initial introductions in many communities [11]. This makes influenza 
virologists and healthcare officials fear that further mutations in the 2009 A(H1N1) virus 
could also lead to a potentially more dangerous second wave in subsequent months. 
Thus, in-depth studies on the 1918 pandemic strains as well as their post-pandemic 
decedents should provide critical new insights into the evolution of A(H1N1) in general, 
and the pandemic potential of the 2009 A(H1N1) in particular. 
HA is one of the two major glycoproteins on the surface of influenza virus. It is 
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the primary antigen that elicits host immune response, and is also responsible for binding 
to sialic-acid receptors and for mediating viral entry into host cells [39]. The hallmarks 
of highly pathogenic influenza viruses among human population include easy 
human-to-human transmission as a result of high affinity of HA for human-like a(2,6) 
receptors, and significant difference in sequence and antigenicity of HA with existing 
seasonal and vaccine strains [1,2,39]. It has been demonstrated on 1918 A(H1N1) HA 
that HAi D190 and D225 are key determinants for effective binding to human-like a(2,6) 
receptors and consequently high infectivity of the virus among human population 
[11,40,41,42]. A single mutation D225G reduced the binding affinity for a(2,6) 
receptors [41,42] and the infectivity of the virus [40], while a double variant 
D190E/D225G rendered the HA non-binding to a(2,6) receptors [41,42] and the virus 
non-infectious [40]. 
In A(H3N2) virus, HA is the major agent for host-driven antigenic drift [43,44], 
However, it is unclear whether or not and, if yes, how human immunity imposes selection 
on A(H1N1) HA. In order to address this critical issue, we undertook a systematic 
computational analysis of the evolution of HI HA in the region of HAj, which is the 
primary target for host immunity selection [43]. 
Recent years have witnessed an explosive expansion of available computational 
methods for phylogenetic analysis of selective pressure, including a variety of methods 
that look for different types of positive selection such as diversifying selection, toggling 
selection and directional selection [45,46,47,48,49,50,51,52,53,54] implemented in 
software packages such as HyPhy [55], MrBayes [56,57] and PAML [45]. Here we used 
PAML 4.0 [45] for calculation of heterogeneous selection pressure at each codon and 
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HyPhy [55] for directional selection in 335 non-egg-adapted and 32 egg-adapted human 
A(H1N1) HA sequences. These sequences were from A(H1N1) viruses isolated all 
around the globe between 1918-2009. In addition, we also analyzed 42 classical swine 
A(H1N1) HA sequences for their close relationship to the 2009 A(H1N1) HA. 
In PAML 4.0 [45], a number of models are available: the branch models allow the co 
ratio to vary among branches in the phylogenetic tree and can be used to detect positive 
selection on particular branches [46,58]; the site models allow the co ratio to vary among 
sites and can be used to detect positive selection at particular sites [59,60]; the branch-site 
models allow the co ratio to vary both among sites and among branches [61] and can be 
used to detect positive selection that affects only a few sites in a few branches. 
In this analysis, a large dataset composed of over 300 sequences was used to ensure 
sufficient representative sequences for the total time span of 91 years, which made it 
impractical for the use of branch-site models in our calculations. However, by 
separating the sequences into distinct subgroups based on their phylogenetic relationship 
and applying the site models in PAML 4.0 [45], we successfully detected the branch and 
the specific sites therein that were under host-driven positive selection. Our study 
revealed differential evolutionary trends of A(H1N1) HA since 1918, which provided 
molecular signatures for monitoring future antigenically drifted 2009 pandemic and 
seasonal A(H1N1) influenza viruses. 
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2.3 Results and Discussion 
A) Phylogenetic analysis of human A(H1N1) HA sequences since 1918 
It is known that egg-adapted influenza viruses tend to have non-natural 
host-associated modifications at certain sites of HA sequences [62,63,64]. To eliminate 
the effects of such modifications in our analysis, we selected only 333 HA sequences of 
A(H1N1) viruses between 1918-2009 (as of July 10, 2009) with a well-documented 
record that they had never been passaged in chicken eggs at any stage. Furthermore, 
intragenic recombination may give rise to false positives in subsequent detection of 
positively selected codons [65], thus the Recombination Detection Program (RDP3) [66] 
was used to make sure that all HA sequences used in this study were free of 
recombination, agreeing with previous observations that intragenic recombination is rare 
for HA [67]. The nucleotide sequences of 333 A(H1N1) HAs in the region of HAi 
including the signal peptide, were analyzed by the ClustalW method [68]. The 
phylogeny tree suggested that these HA sequences belong to two major groups: the 
majority of HA sequences from 1918 to 2008 formed group I, and those of the 2009 
A(H1N1) together with a strain isolated in 2007 formed group II (Fig. 2.SI). The 
separation of the 2009 A(H1N1) HAs from HAs of established human A(H1N1) viruses 
between 1918-2008, including the 1918 pandemic and the seasonal A(H1N1) viruses, 
was consistent with the proposed swine origin of HAs in these viruses [1,2,3,4,5,6,7,8]. 
The low sequence identity (-73%) between the 2009 A(H1N1) HA with seasonal and 
vaccine A(H1N1) HAs might explain why people were in general immunologically naive 
to the former [8,69]. In fact, there did not exist cross-reactivity between the 2009 and 
seasonal A(H1N1) viruses [8], nor did the vaccination with recent (2005-2009) annual 
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vaccines provide immune protection against the 2009 A(H1N1) virus [69]. 
Table 2.1: The values of log-likelihood (l), d^/ds, and parameter estimates in CODEML analysis 
of human A(H1N1) HAs 
Model l d^/ds Parameters estimates 
I-i 1918-1919 (5 strains)1 
MO (one-ratio) -806.78 0.516 co=0.516 
Mia (nearly neutral) -805.91 0.323 Po=0.677 (>,=0.323), <a0=0 (co,=l) 
M2a (positive selection) -804.19 0.564 p0=0.963,p,=0 (p2=0.037), to0=0 (co,=l), co2=15.421 
M7 (beta) -805.92 0.300 p=0.005, <7=0.012 
M8a (beta&co=l) -805.91 0.323 p0=0.846 O,=0.154), p=0.005, <7=0.020, cos=l 
M8 (beta&co>l) -804.19 0.561 po=0.963 (p,=0.037), jO=0.005, <7=7.228, cos=15.242 
I-ii 1979-2000 (45 strains)2 
MO (one-ratio) -2489.23 0.223 co=0.223 
Mia (nearly neutral) -2486.25 0.242 p0=0.&55 (pi=0.145), co0=0.113 (coi=l) 
M2a (positive selection) -2486.25 0.242 Po=0.&55, /?I=0.056 (P2=0.089), co0=0.113 (C»I=1), CO2=1 
M7 (beta) -2485.63 0.232 p=0.327, 9=1.074 
M8a (beta&co=l) -2485.63 0.232 p0=l (pi=0),/?=0.327, <7=1.074, cos=l 
M8 (beta&co>l) -2485.63 0.232 p0=l (p,=0), p=0.327, <7=1.074, cos=l 
l-iii 2000-2001 (22 strains)2 
MO (one-ratio) -1686.21 0.279 co=0.279 
Mia (nearly neutral) -1684.58 0.261 p0=0.793 (p,=0.207), co0=0.068 (co,=l) 
M2a (positive selection) -1683.09 0.287 p0=0.994,pi=0 (p2=0.006), co0=0.225 (a>i=l), co2=10.636 
M7 (beta) -1684.52 0.265 p-0.046, <7=0.127 
M8a (beta&co=l) -1684.58 0.261 p0=0.793 (pi=0.207),p=1.211, 9=98.93, cos=l 
M8 (beta&co>l) -1683.10 0.287 p0=0.994 (p,=0.006), p=28.774, <7=99, ros=10.638 
I-/v 2001-2007 (89 strains)2 
MO (one-ratio) -2720.83 0.187 co=0.187 
M1 a (nearly neutral) -2709.20 0.181 p0= 0.883 (p,= 0.117), co0=0.072 (co,=l) 
M2a (positive selection) -2708.27 0.187 p0= 0.906, pi=0.076 (p2=0.018), co0=0.085 (co,=l), 
CO2=1.915 
M7 (beta) -2708.99 0.183 p=0.137, 9=0.612 
M8a (beta&co=l) -2709.40 0.180 /?o=0.885 (pi=0.115),p=1.81\, q=98.995, cos=l 
M8 (beta&co>l) -2708.82 0.186 Po=0.973 (pi=0.027), p=0.375, q=2.298, ras=1.936 
I-v 2006-2008 (100 strains)2 
MO (one-ratio) -3871.33 0.303 co=0.303 
Mia (nearly neutral) -3813.28 0.241 Po=0.828 (pi=0.172), co0=0.082 (co,=l) 
M2a (positive selection) -3782.07 0.313 p0=0.807, p,=0.188 (p2=0.005), ©0=0.083 (co,=l), 
(02=11.142 
M7 (beta) -3814.21 0.246 p=0.139, <7=0.427 
M8a (beta&co=l) -3812.40 0.231 Po=0.862 (pi=0.138),p=0.497, <7=3.969, cos=l 
M8 (beta&co>l) -3781.55 0.305 p0=0.994 (prO.OOe^p^.lSO, 9=0.546, cos=10.554 
H 2007-2009 (74 strains)2 
MO (one-ratio) -2374.98 0.277 co=0.277 
Mia (nearly neutral) -2373.20 0.282 p0=0.922 Oc,=0.078), (oo=0.222 (<D,=1) 
M2a (positive selection) -2372.81 0.282 p0=0.922, /7!=0.035 (p2=0.042), (o0=0.222 (co,=l), (o2=l 
M7 (beta) -2373.21 0.281 1.218, <7=3.079 
M8a(beta&co=l) -2374.03 0.282 p0=0.945 (pi=0.055),^=3.243, 9=10.201, cos=l 
M8 (beta&co>l) -2372.81 0.282 p0=0.946 Oo,=0.054),p=3.158, 9=9.900, oos=l 
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1
 Due to the inclusion of two partial sequences of A/London/1/1918 and A/London/1/1919 
in this subgroup, the analysis was performed on a total of 187 amino-acid residues that 
covered the antigenic and receptor-binding sites in the region of HAi (51-237) [11]. 2 
The analysis was performed on the first 340 residues of HAi including the signal peptide. 
Table 2.2: LRT tests for HA t sequences of human A(H1N1) influenza viruses 
LRT (M2a - Mia ) LRT (M8 - M7) (2Al) LRT (M8 - M8a) (2Al) 
(2Al) (p-values)1 (p-values)1 (p-values)2 
1- /1918-1919(5 strains) 3.44 (0.1791) 3.46 (0.1773) 3.44 (0.0318) 
I-n 1979-2000 (45 strains) 0 0 0 
l-iii 2000-2001 (22 strains) 2.98 (0.2254) 2.84 (0.2417) 2.96 (0.0427) 
I-i'v 2001-2007 (89 strains) 1.86 (0.3946) 0.34 (0.8437) 1.16(0.1407) 
I-v 2006-2008 (100 strains) 62.42 (0.0000) 65.32 (0.0000) 61.70(0.0000) 
II 2007-2009 (74 strains) 0.78 (0.6771) 0.80(0.6703) 2.44 (0.0591) 
' We used the degree of freedom of 2 for these LRT tests that is expected to be too conservative. 
2
 The p-values were calculated from %2 distribution using degree of freedom of 1 that was then 
divided by a factor of 2 for the mixture distribution, as suggested by the author of PAML 4.0. 
B) Evidence for host-driven antigenic drift in human A(H1N1) HAs 
In order to understand whether host-driven antigenic drift is imposed on the 
evolution of HAi of A(H1N1) virus, we used likelihood ratio tests (LRT) in the software 
package PAML 4.0 [45] to identify the presence or absence of positive selection. In this 
context, positive selection referred to a significant excess of amino-acid altering 
(non-synonymous) substitutions over silent (synonymous) substitutions in nucleotide 
sequences. Large LRT values (or small p-values) between alternative models and null 
models, such as M2a vs. Mia, M8 vs. M7, or M8 vs. M8a, led to the rejection of the null 
51 
models. 
Since HA sequences of group I was further divided into five subgroups (Fig. 2.S1), 
the PAML calculation was carried out on each of these five subgroups and on group II 
(Table 2.1). For group I-z that included three 1918 pandemic A(H1N1) HAs, in order to 
increase the sample size, we also included two partial sequences, A/London/1/1918 and 
A/London/1/1919 [11]. Except for the subgroup I-v, all other subgroups of group I had 
very low LRT values and large p-values (Table 2.1, 2.2), indicating predominantly neutral 
or purifying selection. These results were consistent with the overall low prevalence of 
A(H1N1) virus during the period of 1979-2006 [70], and agreed well with a previous 
study that focused on 1995-2005 A(H1N1) isolates where no positive selection was 
detected [71]. In sharp contrast, group I-v 2006-2008 had co>10 and LRT>60, which 
provided strong evidence for positive selection (Table 2.1, 2.2) and agreed with the 
necessity to update the A(H1N1) vaccine strain using A/Brisbane/59/07 for the 
2008-2009 season. Group II including 73 HAs of 2009 A(H1N1) and one of 2007 
A(H1N1) also had a very low LRT rate ratio (Table 2.1, 2.2). Given the largely 
nonexistence of human immunity against the 2009 A(H1N1), the lack of positive 
selection among group II was expected. However, with more mild infections rapidly 
propagating among human population in the first wave, the gradually established human 
immunity might drive positive selection in future isolates of 2009 A(H1N1) strains. 
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Table 2.3: Codons under positive selection in HAi of human A(H1N1) influenza 
viruses 
Positively selected sites1 
I-v 2006-2008 
(100 strains) 
M2a 156 (97.5%), 190 (100%) 
M8 156 (99.7%), 190 (100%) 
'Positively selected sites from PAML 4.0 [45] using Bayes Empirical Bayes analysis [72]. 
Only codons with greater than 95% posterior probabilities to be under positive selection 
were listed with the corresponding posterior probabilities shown in parentheses. 
Figure 2.1: Antigenic structure and positive selection of A(H1N1) HA. 
a) Antigenic structure of A/PR/8/34 (H1N1) HA (PDB accession code 1RU7 [78]). Five 
antigenic sites were identified by using a large number of monoclonal antibodies [73,74]: 
Sa (cyan), Sb (red), Cal (yellow), Ca2 (green), Cb (blue), using H3 HA numbering. The 
receptor-binding site (RBS) was labeled for reference. b) Codons on A(H1N1) HA 
that were identified to be under various selection in PAML and HyPhy analysis. 
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C) Identification of positively selected codons in human A(H1N1) HAs 
In order to understand how HI HA sequences were positively selected by human 
existing immunity, the CODEML [72] program in PAML 4.0 was used on subgroup I-v in 
which about 0.6% codons were found to be under positive selection (Table 2.1, 2.2). 
Both M2a and M8 models identified HA] 156 and 190 with greater than 95% posterior 
probabilities to be under positive selection (Table 2.3). In previous studies, the antigenic 
structure of HI HA (A/PuertoRico/8/1934) had been determined to include five distinct 
antigenic sites on the globular domain: Sa, Sb, Cal, Ca2 and Cb [73,74] (Fig. 2.1a). 
Both of these positively selected codons were located on the site Sb (Fig. 2.1b). The 
focus of positive selection on the Sb antigenic site was consistent with a cross-reactivity 
analysis of various epidemic H1N1 strains using monoclonal antibodies that it was under 
much higher pressure for mutations [74], 
HAi 138, 186, 190, 194, 225, 226 and 228 had been previously shown to affect 
receptor binding to HI HA [75,76]. Among them, two residues, HAi 190 and 225, play 
predominant roles in determining the receptor-binding specificity of HI HA: D190/D225 
for a(2,6) receptors in humans, D190/G225 for a(2,6) and a(2,3) receptors in swine, and 
El90/G225 for a(2,3) receptors in avian [11,39,40,41,42,76]. Although changes at these 
two sites had been previously reported to cause antigenic drift in A(H1N1) epidemic 
strains [77], it was a somewhat common belief that key determinants of receptor-binding 
specificity are in general not subject to selection. Thus, the strong positive selection at 
HAi 190 within subgroup I-v is quite unexpected. 
D) Positive selection of egg-adapted human A(H1N1) HAs during 1933-1979 
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Table 2.4: The values of log-likelihood (1), and parameter estimates in 
CODEML analysis of egg-adapted human A(H1N1) HAs between 1933-1979 
Model 1 dN/ds Parameters estimates 
1933-1979 (32 strains)1 
MO (one-ratio) - 3 3 3 6 . 0 1 0 . 4 1 1 © = 0 . 4 1 1 
Mia (nearly neutral) - 3 2 8 3 . 7 5 0 . 3 3 6 po=0.705 G?i=0.295), co0=0.057 (coj=l) 
M2a (positive - 3 2 7 5 . 2 4 0 . 4 5 4 po=0.72\, px=0.234 O 2 = 0 . 0 4 6 ) , CO0 = 0 . 0 7 9 
selection) ( © i = 1 ) , 0 ) 2 = 3 . 5 7 1 
M7 (beta) - 3 2 8 5 . 5 6 0 . 3 4 5 / ? = 0 . 0 6 8 , < 7 = 0 . 1 2 9 
M8a (beta&co=l) - 3 2 8 3 . 7 8 0 . 3 3 6 p o = 0 . 7 0 5 (p i=0 .295 ) , p=6.100, q=99, ©s= =1 
M8 (beta&co>l) - 3 2 7 5 . 4 1 0 . 4 5 2 / ? o = 0 . 9 4 2 ( p i = 0 . 0 5 8 ) , p=0.206, q= = 0 . 5 3 4 , 
cos=3.283 
1947-1957 (12 strains)1 
MO (one-ratio) - 2 0 6 8 . 0 1 0.435 ©=0.435 
Mia (nearly neutral) - 2 0 5 6 . 2 7 0.337 p0=OM9 ( p i = 0 . 3 1 1 ) , © o = 0 . 0 3 8 (©i=l) 
M2a (positive -2046.27 0.501 j t ? o = 0 . 9 6 7 , p\=0 O ? 2 = 0 . 0 3 3 ) , © 0 = 0 . 2 5 6 (©,=1), 
selection) ©2=7.651 
M7 (beta) - 2 0 5 6 . 4 4 0.324 /?=0.012, q=0.023 
M8a (beta&co=l) - 2 0 5 6 . 2 8 0.337 p0=0.688 (pi=0.312),^-3.886, q=99, ©s= =1 
M8 (beta&co>l) -2046.29 0.501 ^ o = 0 . 9 6 7 ( p i = 0 . 0 3 3 ) , ^ = 3 4 . 1 4 1 , q=99, 
©s=7.667 
1948-1979 (17 strains)1 
MO (one-ratio) -1759.58 0.385 ©=0.385 
Mia (nearly neutral) - 1 7 5 1 . 4 6 0 . 2 6 0 / ? o = 0 . 7 4 0 ( p i = 0 . 2 6 0 ) , © 0 = 0 (©,=1) 
M2a (positive -1747.17 0.408 ; ? o = 0 . 7 9 4 , / ? i = 0 . 1 6 8 (p2=0.039), © 0 = 0 (©i=l), 
selection) ©2=6.226 
M7 (beta) - 1 7 5 1 . 6 1 0.300 p=0.005, 9 = 0 . 0 1 2 
M8a (beta&co=l) - 1 7 5 1 . 4 6 0 . 2 6 0 / ? o = 0 . 7 4 0 ( p i = 0 . 2 6 0 ) , ^ = 0 . 0 0 5 , ^ = 2 . 3 5 0 , ©s=l 
M8 (beta&co>l) -1747.19 0.411 po=0.969 0,-0.031), p=0.006, q= = 0 . 0 2 5 , 
©s=6.964 
1
 The analysis was performed on the first 337 residues of HAi including the signal 
peptide. 
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Table 2.5: LRT tests and codons under positive selection for HAi sequences of 
egg-adapted human A(H1N1) influenza viruses between 1933-1979
 i 
LRT (2A1) 
(p-values) 
Positively selected sites' 
1933-1979 
(32 strains) 
M2a M2a-Mla 17.02 (0.0002) 77 (95.8%), 225 (98.8%) 
M8 M8-M7 20.30 (0.0000) 77 (98.7%), 225 (99.6%), 227 
(97.7%) M8-M8a 16.74 (0.0000) 
1947-1957 
(12 strains) 
M2a M2a-Mla 20.0 (0.0000) 143 (99.3%), 264 (99.6%) 
M8 M8-M7 20.30 (0.0000) 143 (99.6%), 166 (95.1%), 264 
(99.7%) M8-M8a 19.98 (0.0000) 
1948-1979 
(17 strains) 
M2a M2a-Mla 8.58 (0.0137) 225 (99.1%) 
M8 M8-M7 8.84 (0.0120) 225 (99.8%) 
M8-M8a 8.54 (0.0017) 
Positively selected sites from PAML 4.0 [45] using Bayes Empirical Bayes analysis [72]. 
Only codons with greater than 95% posterior probabilities to be under positive selection 
were listed with the corresponding posterior probabilities shown in parentheses. 
Highlighted in bold were codons that were not associated with egg-adapted substitutions 
[62,63,64], 
To compensate for the lack of non-egg-adapted human A(H1N1) HAs for the period 
of 1933-1978, we separately collected a total of 32 different egg-adapted A(H1N1) HA 
sequences between 1933-1979 that were free of sequence ambiguity (Fig. 2.S2). These 
sequences as a group were analyzed by PAML 4.0, as well as two subgroups that covered 
the periods of 1947-1957 (12 sequences) and 1948-1979 (17 sequences) (Table 2.4, 2.5), 
keeping in mind of the egg-adapted mutations at HAi 138, 144, 163, 189, 190, 225, and 
226 [62,63,64], The two subgroups 1947-1957 and 1948-1979 represented A(H1N1) 
viruses circulating in the 1950s and in the 1970s upon its reemergence in 1977, 
respectively. Given the close genetic and antigenic similarity of the reappeared A(H1N1) 
influenza virus in 1977 with the A(H1N1) viruses isolated in 1950 [22,23,24], it was of 
particular interest to investigate whether different evolutionary trends were adopted by the 
1947-1957 and 1948-1979 subgroups. 
5 6 
1948-1979 
1947-1957 
6 4 2 0 
Nucleotide Substitutions (x100) 
Figure 2.S2: Phylogenetic tree of 32 HA sequences of egg-adapted human A(H1N1) 
influenza viruses isolated between 1933~1979. 
For both the entire group 1933-1979 and the subgroup 1947-1957, comparisons of 
M2a-Mla, M8-M7, or M8-M8a yielded large LRT values and very small jo-values, 
suggesting the presence of positive selection at about 5% and 3% codons, respectively 
(Table 2.4, 2.5). However, it is noteworthy that the subgroup 1948-1979 had much 
smaller LRT values, suggesting that the positive pressure of the entire group 1933-1979 
be mostly from the contribution of the subgroup 1947-1957. 
We further employed the CODEML in PAML 4.0 to analyze the positively 
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selected codons in each group. The results were shown in Table 2.5 where highlighted 
in bold were the codons not known to be possible egg-adapted mutations (HAi 138, 144, 
163, 189, 190, 225, and 226) [62,63,64], For the entire group 1933-1979, HA, 77, 225 
and 227 were found to be under positive selection with greater than 95% posterior 
probability in model M8 (Fig. 2.1b). They were located in the antigenic sites Cb (HAi 
77) and Ca2 (HAi 225 and 227), respectively (Fig. 2.1b). In addition, for the subgroup 
1948-1979, HAi 225 was found to be under positive selection with greater than 99% 
posterior probability in both models M2a and M8. However, given the fact that these 
HAs were from egg-adapted A(H1N1) viruses in which HA, 225 was one of the most 
frequently changed site [62,63,64], and the predominant residue at this site (Table 2.6), 
G225, was commonly found in swine and avian A(H1N1) HAs, it was possible that the 
changes at HA, 225 was due to positive selection imposed by adaptation in eggs. At 
posterior probability of 90%, HAi 138 and 189 were positively selected as well, however, 
both sites were involved in egg-adapted substitutions [62,63,64]. In sharp contrast, 
however, HA] 143, 166 and 264 in the subgroup 1947-1957 were found to be under 
positive selection (Table 2.5), none of which was among the previously identified 
egg-adapted mutations. Antigenically, these codons were located in the antigenic sites 
Ca2, Sa and Cb, respectively (Fig. 2.1b). For their relatively distant location from the 
receptor-binding site, HAi 143, 166 and 264 are probably mutations driven by existing 
human immunity for antibody escape. 
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Table 2.6: Codons at HAi 190 and 225 in human and swine A(H1N1) influenza 
viruses 
D190 Non-D190 D225 G225 Non-D225/G225 
Human 1979-2008 Epidemic (575 sequences) 477 (83.0%)" 98(17.0%) 565 (98.2%) 2 (0.4%) 8(1.4%) 
Human 1918 Pandemic (5 sequences) 5 (100%) 0 3 (60%) 2 (40%) 0 
Human 2009 Pandemic (73 sequences) 73 (100%) 0 69 (94.5%) 1 (1.4%) 3 (4.1%) 
Human 1947-1957 (12 strains) (egg-adapted) 9 (75%) 3 (25%) 2(16.7%) 10(83.3%) 0 
Human 1948-1979 (17 strains) (egg-adapted) 16(94.1%) 1 (5.9%) 4 (23.5%) 13 (76.5%) 0 
Swine 1990-2009 (42 sequences) 41 (97.6%) 1 (2.4%) 28 (66.6%) 12(28.6%) 2 (4.8%) 
The number of cases that a particular type of residues occurs at each site. Shown in 
parenthesis was the occurrence in percentage. 
Thus, there appeared to have different evolutionary patterns for the subgroup 
1947-1957 circulating in the 1950s and the subgroup 1948-1979 circulating mostly in 
the 1970s. The former subgroup was subjected to positive selection pressure at HAi 143, 
166 and 264 (Table 2.5), and had a much larger variability at HA] 190, with 25% being 
non-D190 (Table 2.6). In marked contrast, the latter subgroup was probably not under 
host-driven positive selection in humans and had highly conserved HAi 190 (94.1% being 
D190). 
E) Evolution of swine A(H1N1) HAs during 1990-2009 
Table 2.7: The values of log-likelihood (l), dN/ds, and parameter estimates in CODEML analysis 
of swine A(H1N1) HAs between 1990-2009 
Model 1 dN/ds Parameters estimates LRT (2Ai) (p-\alues) 
M0 (one-ratio) -6021.08 0.158 co=0.158 
Mia 
(nearly neutral) 
-5949.30 0.217 /?o=0.864 (pi=0.136), co0=0.094 
(0D, = 1) 
LRT (M2a-Mla) = 1.24 (0.5379) 
M2a(positive 
selection) 
-5948.68 0.224 p0=0.864, pr0.134 (p2=0.002), 
<o0=0.095 (co,=l), ©2=3.682 
M7 (beta) -5925.79 0.174 p= 0.381, 9=1.768 LRT (M8-M7) = 6.78 (0.0337) 
M8a(beta&co=l) -5924.10 0.171 p0=0.970 (pi=0.030), /?=0.460, 
9=2.617, cos=l 
LRT (M8-M8a) = 3.40 (0.0326) 
M8 (beta&co) -5922.40 0.177 p0=0.995 O,=0.005), p=0.413, 
9=2.052, cos=2.546 
The analysis was performed on the first 338 residues of HAi including the signal peptide. 
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Figure 2.S3: Phylogenetic tree of 42 HA sequences of swine A(H1N1) influenza viruses 
isolated between 1990-2009. 
Given the swine origin of the 2009 pandemic A(H1N1) HA, we also analyzed 42 
non-redundant, non-ambiguous swine A(H1N1) HA sequences during 1990-2009 
available from GISAID/Epifludb (Table 2.7, Fig. 2.S3). The reason that we focused on 
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this period was mainly for the antigenic stasis of swine A(H1N1) until 1998 [8] since the 
introduction of the 1918 "Spanish" A(H1N1) virus into swine [1,2,3,4,5,6,7,8], Overall, 
the alternative models M2a and M8 fitted the data only marginally better than the null 
models Mia, M7 and M8a, respectively (Table 2.7). Thus, it seemed that swine 
A(H1N1) HAs during 1990-2009 were not subjected to strong host-driven positive 
selection. 
T a b l e 2 .8 : D i r e c t i o n a l s e l e c t i o n a n a l y s i s o n h u m a n A ( H 1 N 1 ) H A s 
Tree L Residue P-Value Bias Proportion (%) No. of Sites 
Human I-v (100 sequences) 0.474 T 0.0002 32.995 5.4 2 
R 0.0002 12.583 11.8 1 
V 0.0004 34.478 4.0 2 
K 0.0023 29.301 7.2 1 
Human 1933-1979 (32 strains) 
(egg-adapted) 
0.613 D 0.0000 78.148 3.4 1 
Human 1948-1979 (17 strains) 
(egg-adapted) 
0.091 D 0.0007 133.611 5.1 1 
Table 2.9: Sites found to be under directional selection in human A(H1N1) HAs 
Sites Composition Root Preferred Inferred 
Substitutions 
Human I-v 
(100 sequences) 
143 V99T1 V V T — > ] V 
156 G90R9E1 R R G - h E , G - > 7 R 
158 N 9 6 K 4 N K n - > 4 k 
190 D 6 7 N 2 5 V g D V D - h 6 N , D - » 4 V 
193 A52T48 A T A ^ 6 t 
197 T82K18 T T k - » 2 t 
H u m a n 1 9 3 3 - 1 9 7 9 
(32 strains) (egg-adapted) 
2 2 5 G23D9 D D D - » , G , G - > 6 D 
H u m a n 1 9 4 8 - 1 9 7 9 
(17 strains) (egg-adapted) 
2 2 5 g 1 3 d 4 G D g - > 4 d 
F) Directional evolution of human A(H1N1) HAs 
In order to test whether directional evolution of protein sequences existed in the 
evolution of human A(H1N1) HAs, we employed a maximum likelihood method 
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developed by Kosakovsky Pond and colleagues [49]. In each subgroup, we used the 
oldest HA sequence as the root. In agreement with CODEML analysis reported in 
previous sections, among all non-egg adapted human A(H1N1) HAs, directional 
evolution was only identified in the subgroup I-v, at sites HAi 143, 156, 158, 190, 193 
and 197 (Table 2.8, 2.9). HA, 143 belonged to the antigenic site Ca2 of A(H1N1) HA, 
whilst all other sites were located in the antigenic site Sb (Fig. 2.1b). Among these sites, 
HAi 156, 190 and 193 were identified by CODEML in PAML 4.0 to be under positive 
selection with 99.7%, 100%, and 80.9% posterior probability in model M8, respectively 
(Table 2.3). In previous structural studies, residue HAi 190 in 1934 human A(H1N1) 
HA and HAi 190 and 193 in 1930 swine A(H1N1) HA were found to directly interact 
with bound human-like a(2,6)-receptors [78]. Thus, it remains to be investigated the 
impacts of directional evolution at HAi 190 and 193 on receptor binding and antigenic 
drift. 
We also performed directional evolution study on egg-adapted human A(H1N1) HA 
sequences, and found that in both the entire group 1933—1979 and the subgroup 
1948-1979, multiple favored mutations of D225->G and G225->D were detected (Table 
2.8, 2.9). Given its involvement in egg-adaptation, the directional evolution at HAi 225 
may be the consequence of egg-adaptation. In contrast, no residues in the subgroup 
1947-1957 were identified to be under directional selection. 
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G) Evolution of human and swine A(H1N1) HAs at HAi 190 and 225 
For their predominant roles in determining receptor-binding specificity of A(H1N1) 
HA, and the positive selection on HAi 190 in the subgroup I-v, we further investigated 
the evolution of HAt 190 and 225 in A(H1N1) strains during 1918-2009. These 
included 653 non-egg-adapted HAs (five pandemic HAs from 1918-1919, 575 epidemic 
HAs from 1979-2008, and 73 pandemic HAs from 2009), and 42 swine HAs (Table 2.6). 
For the 575 epidemic HAs, HAi 190 was highly variable (17.0% sequences did not have 
D190), while HAi 225 was more conserved (only 1.8% sequences did not have D225) 
(Table 2.6). Among all the deviations (a total of 107 cases) from the ideal D190/D225 
combination for human A(H1N1) viruses, two predominant ones were N190/D225 
(69.2%) and V190/D225 (19.6%). At present, we don't know the exact effects of these 
mutations, or in combination with other concurring mutations at or around the 
receptor-binding site, on binding to human receptors. Further experiments are needed to 
clarify these issues. However, in previous studies, a single mutation D190N of A(H1N1) 
HA was shown to result in a lower binding affinity for human-like a(2,6) receptors, and a 
higher binding affinity for avian-like a(2,3) receptors [64]. 
The five HA sequences retrieved from victims of 1918 "Spanish" A(H1N1) influenza 
virus shared 98.9% to 99.8% sequence identity [11]. Among them, there were two 
non-synonymous substitutions of D225G, one in A/New York/1/1918 and the other one in 
A/London/1/1919 (Table 2.6). The HAs harboring the mutation D225G had reduced 
binding affinity for human receptors [11,40,41], 
In the 73 HA sequences from the 2009 pandemic A(H1N1), D190 was strictly 
conserved, while D225 was 94.5% conserved (Table 2.6). At HAi 225, the deviations 
were 1.1% for G225 and 3.3% for E225. Thus, the complete conservation at HAi 190 
and the nearly complete conservation at HAi 225 were consistent to the importance of 
these residues in allowing for binding to human-like a(2,6) receptors [40,41], supporting 
the substantially higher human-to-human transmissibility of the 2009 A(H1N1) virus than 
seasonal A(H1N1) viruses [5,8]. 
Therefore, there were two distinct evolutionary trends in host-driven antigenic 
drift of human A(H1N1) HAs at residues in the receptor-binding site: the 1918 pandemic 
HAs underwent antigenic drift at HA, 225, while the epidemic HAs undertook antigenic 
drift at HA, 190. In the absence of selection, the 2009 A(H1N1) viruses were highly 
conserved at both HA, 190 and 225, which was distinct from those two host-selected 
evolutionary trends (Table 2.6). With gradually established immunity among human 
population, we wondered how the 2009 A(H1N1) virus would undergo antigenic drift in 
the months to come. Thus, we also looked at the conservation at HAi 190 and 225 in 42 
swine A(H1N1) HA sequences (Table 2.6). Surprisingly, among these sequences, D190 
was conserved at 97.6%, while D225 and G225 were observed at 66.6% and 28.6%, 
respectively. The similarly high variability of HAi 225 in swine A(H1N1) HAs with 
that of 1918 pandemic HAs was consistent with the relative antigenic stasis of swine 
A(H1N1) until 1998 [8] and agreed well with the suggestion that the introduction of the 
2009 pandemic A(H1N1) virus into humans be a single event or multiple events of similar 
viruses [1,2,3,4,5,6,7,8]. 
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The deviations from the ideal D190/D225 combination in A(H1N1) HAs might 
result in reduced binding to human receptors [11,41,42,64,79]. However, two 
possibilities, which are not mutually exclusive, may explain the fact that mutations are 
frequently observed at these two sites: one is that other concurring mutations at or around 
the receptor-binding site may sufficiently maintain the receptor binding affinity so that the 
overall binding affinity is largely unaffected; the second is that the gain in evading 
antibody neutralization far overweighs the reduction in receptor binding. Due to the 
overlapping locations of the ever-changing antigenic sites and the more-conserved 
receptor-binding site of HA, there is a constant dilemma of whether or not a residue at the 
receptor-binding site should change. Although the involvement of residues in antigenic 
drift that are critical for receptor binding was also observed in HAs of other types and 
subtypes including influenza B virus HA [80], H3 [43,44]and H5 HA [44,81], the 
interplay between these two opposing forces in HA evolution is still very poorly 
understood. Although previous studies on A(H3N2) HAs suggested covariation of 
antigenicity and receptor-binding specificity as a possible mechanism for the antigenic 
differences observed in viruses propagated in different cells [82], questions such as how 
residues involved in receptor binding are actively utilized for antigenic drift in influenza 
evolution in the same hosts need to be urgently addressed in order for us to comprehend 
the powerful strategies that the virus employs for recurring influenza infections. 
H) Implications for the 2009 pandemic 
By analyzing hundreds of A(H1N1) HA sequences between 1918-2009, our study 
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revealed positive selection in the subgroup I-v of A(H1N1) HAs. The positively selected 
codons were located at HAi 156 and 190 in the Sb antigenic site [83]. It was surprising 
that HA] 190, which is critical for receptor-binding specificity of A(H1N1) HAs, was also 
under positive selection. Through further analysis of HA, 190, together with HAi 225, 
the other critical determinant for receptor-binding specificity of A(H1N1), we found 
that the epidemic HAs and the 1918 pandemic and swine HAs favored one of these two 
sites for antigenic drift. Whether the 2009 pandemic A(H1N1) HA will adopt any of 
these two trends, or use a novel mechanism that does not involve HAt 190 and 225, will 
unfold in the coming months. If the latter is to be used, the 2009 A(H1N1) viruses may 
maintain their intrinsic high transmissibility, which, together with mutations in other 
genes such as NS1 and PB1-F2 with signatures of elevated pathogenicity [1,2], may 
suffice a new disastrous pandemic in the near future. 
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2.4 Materials and Methods 
A) Phylogenetic analysis of A(H1N1) HAs 
We obtained all available HA sequences (over 1,000) of non-egg-adapted A(H1N1) 
viruses for the period of 1918-2009 (as of July 10, 2009) from GISAID/Epifludb. We 
then removed the sequences with one or more ambiguous nucleotide sequences within the 
HA, region and deleted identical sequences. This gave us a dataset of 652 HA 
sequences that included three 1918 pandemic HAs, 575 epidemic HAs from 1979-2008 
that collectively formed group I, and 73 pandemic HAs from 2009 and one HA from 2007 
that belonged to group II. To facilitate the speed of computing, we further removed 
closely related sequences and obtained a dataset of 333 HA sequences. The program 
RDP3 (http://darwin.uvigo.es/rdp/rdp.html) [66] was used to make sure that no 
recombination was present in any of these HA sequences. The ClustalW method [68] 
with the MEGALIGN program of DNASTAR package (www.dnastar.com) was used for 
phylogenetic analysis of HI HA sequences in the region of HAi (Fig. 2.SI). 
Due to the historic use of eggs for amplification of influenza viruses before 
sequencing, there presented a vacuum in sequence for non-egg-adapted A(H1N1) viruses 
between 1919 and 1979. In order to gain insights into the evolution of A(H1N1) viruses 
for this period, we separately collected a total of 32 different egg-adapted A(H1N1) HA 
sequences between 1933-1979 that were free of sequence ambiguity (Fig. 2.S2). These 
sequences were similarly analyzed while keeping in mind of the possible egg-adapted 
mutations at HA, 138, 144, 163, 189,190, 225, and 226 [62,63,64]. 
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In order to compare the evolution of swine A(H1N1) HA sequences, we also 
retrieved 42 unique swine HI HA sequences for the period of 1990-2009 that were free 
of ambiguous nucleotide sequences (Fig. 2.S3). The reason that we focused on 
1990-2009 was that previous studies suggested that swine A(H1N1) viruses be 
antigenically stable for the period of 1930 to 1990s [84], 
B) Analysis of positive selection by PAML 4.0 
The site-specific models implemented in the CODEML program in PAML 4.0 [45] 
was used to calculate heterogeneous selection pressure at amino-acid positions 
[45,54,72,85]. The models used in this study were M0, Mia, M2a, M7 and M8. Mia 
(nearly neutral), M7 (beta) and M8a (beta and co=l) were null models that did not support 
to > 1. In contrast, the alternative models M2a (positive selection) and M8 (beta and m), 
compared to Mia and M7 respectively, each had an additional class that allowed co > 1. 
Likelihood ratio tests (LRT) comparing M2a versus Mia, M8 versus M7, and M8 versus 
M8a provided test for the existence of positive selection. In the test, twice the log 
likelihood difference, 2A1 = 2(li-lo), was calculated where li and lo were the log 
likelihoods for the alternative model and null model, respectively. A larger value of LRT 
over those of x2 distribution led to rejection of the null models [72]. In order to 
calculate the codon-substitution models for heterogeneous selection pressure at each 
codon, the Bayes Empirical Bayes (BEB) analysis implemented in CODEML [72] was 
used, which has been shown to yield robust results even for small datasets. For all 
calculations, multiple runs, each with different initial parameter values, were performed 
to ensure optimization and convergence. 
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C) Directional evolution of protein sequences using HyPhy 
Each group of A(H1N1) HA sequences aligned by the ClustalW method (Fig. 2.SI, 
2.S2, 2.S3) was input to the PhyML program [86] to generate an unrooted phylogenetic 
tree, which was then rooted using the Treeview software [87] by selecting the oldest 
sequence in each group as the root/ancestor. This rooted phylogenetic tree was used for 
directional evolution of protein sequences [49] implemented in the HyPhy [55] software 
package. 
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